Brief: Lisata Therapeutics Says On May 1, Eliminated Position Of President & Chief Business Officer
01/05/2023 23:02
May 1 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS - ON MAY 1, ELIMINATED POSITION OF
PRESIDENT
& CHIEF BUSINESS OFFICER, TERMINATED EMPLOYMENT OF DAVID SLACK,
EFFECTIVE IMMEDIATELY
Source text for Eikon: ID:
Further company coverage: LSTA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal